Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

B-Cell CLL/lymphoma 2 (BCL2) (N-Term) Peptide

BCL2 Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5686032

Quick Overview for B-Cell CLL/lymphoma 2 (BCL2) (N-Term) Peptide (ABIN5686032)

Target

Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))

Origin

Human

Source

  • 12
Synthetic

Application

Blocking Peptide (BP), BioImaging (BI)
  • Protein Region

    N-Term

    Characteristics

    BCL2 peptide corresponds to 16 amino acids near the N-terminus region of BCL2.
  • Application Notes

    BCL2 Peptide is used for blocking the activity of BCL2 antibody . The BCL2 antibody ships at 0.5 mg/mL and the BCL2 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    BCL2 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target

    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))

    Gene ID

    596

    NCBI Accession

    NP_000624, NP_000648

    OMIM

    72198189

    UniProt

    P10415
You are here:
Chat with us!